Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
Michael Brines(Northwell Health), Anthony Cerami(Araim Pharmaceuticals (United States)), Roberto Latini(Mario Negri Institute for Pharmacological Research), Maddalena Fratelli(Mario Negri Institute for Pharmacological Research), Fabio Fiordaliso(University of Milan), Pietro Ghezzi(Brighton and Sussex Medical School), Giovanni Grasso(University of Palermo), Thomas R. Coleman(University of Messina), Alessandra Sfacteria(University of Messina), Chiao-ju Su-Rick(University of Messina), Deborah Diaz(University of Messina), John E. Smart(University of Messina), Daniel E. Gómez(Regeneron (United States)), Qiao-wen Xie(University of Messina), Eileen G. Pobre(University of Messina)
Cited by 654
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Clinical Relevance of Biomarkers of Oxidative Stress
|Antioxidants and Redox Signaling|2015|906